{
    "organizations": [],
    "uuid": "ad0500e471ce34543f831cdb69ce16b30b581e12",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-bb-biotech-to-propose-330-sfr-divi/brief-bb-biotech-to-propose-3-30-sfr-dividend-for-2017-idUSFWN1PD1IE",
    "ord_in_thread": 0,
    "title": "BRIEF-BB Biotech to propose 3.30 Sfr dividend for 2017",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 19 (Reuters) - BB Biotech AG:\n* SHOWS A DOUBLE-DIGIT TOTAL RETURN FOR 2017 - MID CAPS OVERDELIVER ON INNOVATION AND ARE BECOMING A KEY UPSIDE TRIGGER\n* ‍UNDERLYING PORTFOLIO PERFORMED WELL, ENDING YEAR UP 23.4% IN CHF, 12.5% IN EUR AND 29.2% IN USD​\n* ‍FULL YEAR 2017 DATA SHOWED A NET GAIN OF CHF 688 MN COMPARED TO A NET LOSS OF CHF 802 MN FOR FULL YEAR 2016​\n* ‍WILL PROPOSE A RECORD REGULAR DIVIDEND OF CHF 3.30 PER SHARE AT GENERAL ASSEMBLY ON MARCH 13, 2018​\n* ‍BELIEVES THAT 2018 WILL CONTINUE TO BRING IMPORTANT PRODUCT APPROVALS AND MILESTONES FOR SECTOR AND FOR ITS PORTFOLIO​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-19T14:05:00.000+02:00",
    "crawled": "2018-01-20T17:41:02.008+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "bb",
        "biotech",
        "ag",
        "show",
        "total",
        "return",
        "mid",
        "cap",
        "overdeliver",
        "innovation",
        "becoming",
        "key",
        "upside",
        "trigger",
        "portfolio",
        "performed",
        "well",
        "ending",
        "year",
        "chf",
        "eur",
        "year",
        "data",
        "showed",
        "net",
        "gain",
        "chf",
        "mn",
        "compared",
        "net",
        "loss",
        "chf",
        "mn",
        "full",
        "year",
        "propose",
        "record",
        "regular",
        "dividend",
        "chf",
        "per",
        "share",
        "general",
        "assembly",
        "march",
        "continue",
        "bring",
        "important",
        "product",
        "approval",
        "milestone",
        "sector",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}